Simcere Pharmaceutical Group Ltd
HKEX:2096
Wall Street
Price Targets
Price Targets Summary
Simcere Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for Simcere Pharmaceutical Group Ltd is 9.24 HKD with a low forecast of 7.62 HKD and a high forecast of 12.08 HKD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Simcere Pharmaceutical Group Ltd
For the last 5 years the compound annual growth rate for Simcere Pharmaceutical Group Ltd's operating income is -4%. The projected CAGR for the next 3 years is 38%.
Net Income
Forecast
Net Income Estimate
Simcere Pharmaceutical Group Ltd
For the last 5 years the compound annual growth rate for Simcere Pharmaceutical Group Ltd's net income is -1%. The projected CAGR for the next 3 years is 32%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Simcere Pharmaceutical Group Ltd's stock price target?
Price Target
9.24
HKD
According to Wall Street analysts, the average 1-year price target for Simcere Pharmaceutical Group Ltd is 9.24 HKD with a low forecast of 7.62 HKD and a high forecast of 12.08 HKD.
What is Simcere Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
16%
For the last 5 years the compound annual growth rate for Simcere Pharmaceutical Group Ltd's revenue is 8%. The projected CAGR for the next 3 years is 16%.
What is Simcere Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
38%
For the last 5 years the compound annual growth rate for Simcere Pharmaceutical Group Ltd's operating income is -4%. The projected CAGR for the next 3 years is 38%.
What is Simcere Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
32%
For the last 5 years the compound annual growth rate for Simcere Pharmaceutical Group Ltd's net income is -1%. The projected CAGR for the next 3 years is 32%.